98%
921
2 minutes
20
Background: Accurate preoperative localization is a challenge in thoracoscopic surgery for multiple pulmonary nodules. In this study, we aimed to assess the accuracy and feasibility of electromagnetic navigation (EN)-guided percutaneous localization.
Methods: We enrolled 50 patients with multiple pulmonary nodules for EN-guided (EN group) or CT-guided (CT group) localization. The primary outcome was the localization accuracy, and the primary analysis was to assess the noninferiority (noninferiority margin of 5 mm) of EN-induced localization deviation compared with that of CT-induced deviation. The secondary outcomes included the procedural duration, anxiety score, and incidence of complications.
Results: Among the 50 patients randomized to the EN- and CT-guided groups, 24 patients (53 nodules) underwent EN-guided preoperative marking, and 25 patients (54 nodules) underwent CT-guided preoperative marking. The demographic, clinical, and radiological characteristics did not differ significantly between the groups (P > 0.05). Among these patients, the EN group was noninferior in terms of localization deviation compared with the CT group (9.0 [6.5] vs. 7.5 [6.0] mm; P = 0.33; absolute difference 0.9 [95% CI] 0.03-1.77]). Furthermore, the procedural duration was 16.3 (4.2) minutes for the EN group and 22.3 (8.2) minutes for the CT group (P = 0.002). Additionally, the EN group exhibited significant improvements compared with the CT group on the basis of the Amsterdam Preoperative Anxiety and Information Scale, particularly in relation to the S and C subscales' cumulative scores.
Conclusions: EN was found to be noninferior to CT in terms of localization accuracy, as it significantly decreased the procedural duration and relieved psychological stress for patients who underwent simultaneous surgery for multiple pulmonary nodules.
Clinical Trial Registration: Chinese Clinical Trial Registry Identifier: ChiCTR2200056734.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11608476 | PMC |
http://dx.doi.org/10.1186/s12957-024-03606-z | DOI Listing |
PLoS One
September 2025
Department of Radiology, the Third Affiliated Hospital of Kunming Medical University, Yunnan, Kunming, China.
Purpose: Bronchiolar adenoma (BA) is a rare benign pulmonary neoplasm originating from the bronchial mucosal epithelium and mimics lung adenocarcinoma (LAC) both radiographically and microscopically. This study aimed to develop a nomogram for distinguishing BA from LAC by integrating clinical characteristics and artificial intelligence (AI)-derived histogram parameters across two medical centers.
Methods: This retrospective study included 215 patients with diagnoses confirmed by postoperative pathology from two medical centers.
Cureus
August 2025
Pulmonology, Unidade Local de Saúde (ULS) da Guarda, Guarda, PRT.
Pulmonary atypical adenomatous hyperplasia (AAH) is a recognized precursor lesion to pulmonary adenocarcinoma (ADC). We present the case of a 79-year-old ex-smoker in whom transthoracic needle biopsy revealed histological features suggestive of lung ADC. However, surgical resection of the lesion later demonstrated only AAH.
View Article and Find Full Text PDFCureus
August 2025
Department of Thoracic Surgery, Instituto Guatemalteco de Seguridad Social, Guatemala City, GTM.
Endometrial adenocarcinoma frequently metastasizes to distant organs, with the lungs being a common site. Pulmonary metastases typically present as multiple nodules. However, solitary lesions are uncommon and may offer surgical opportunities.
View Article and Find Full Text PDFTherapeutic treatment of lung nodules by ablation is a new field. Even though not considered standard of care, lung nodule ablation can be appropriate for select cases. Even though ablation is a safe and well-tolerated procedure, bleeding is a potential complication.
View Article and Find Full Text PDFRespirology
September 2025
Radiology Department, Huadong Hospital, Fudan University, Shanghai, China.
Background And Objective: Diagnosing pulmonary ground-glass nodules (GGNs) on chest CT imaging remains challenging in clinical practice. Moreover, different stages of GGNs may require different clinical treatments. Hence, we sought to predict the progressive state of pulmonary GGNs (absorption or persistence) for accurate clinical treatment and decision-making.
View Article and Find Full Text PDF